Orinaz en es it fr

Orinaz Brand names, Orinaz Analogs

Orinaz Brand Names Mixture

  • No information avaliable

Orinaz Chemical_Formula


Orinaz RX_link

No information avaliable

Orinaz fda sheet

Orinaz msds (material safety sheet)

Orinaz MSDS

Orinaz Synthesis Reference

No information avaliable

Orinaz Molecular Weight

270.349 g/mol

Orinaz Melting Point

128.5 oC

Orinaz H2O Solubility

109 mg/L

Orinaz State


Orinaz LogP


Orinaz Dosage Forms

Tablet (250 and 500 mg)

Orinaz Indication

Used as an oral hypoglycemic agent in non-insulin-dependent (type 2) Diabetes Miletus with adult onset.

Orinaz Pharmacology

Tolbutamide, a second-generation sulfonylurea antidiabetic agent, is used with diet to lower blood glucose levels in patients with diabetes mellitus type II. Tolbutamide is twice as potent as the related second-generation agent glipizide. Tolbutamide lowers blood sugar by stimulating the pancreas to secrete insulin and helping the body use insulin efficiently. The pancreas must be able to produce insulin for this drug to work.

Orinaz Absorption

Well absorbed. Absorption is unaltered if taken with food but is increased with high pH.

Orinaz side effects and Toxicity

Oral, mouse: LD50 = 2600 mg/kg

Orinaz Patient Information

Treatment with tolbutamide may increase the risk of death from cardiovascular disease compared to treatment of diabetes with diet alone or diet plus insulin. Discuss with your doctor the risks and benefits of treatment with tolbutamide. Know the signs and symptoms of low blood sugar (hypoglycemia), which include headache, drowsiness, weakness, dizziness, fast heartbeat, sweating, tremor, and nausea. Carry a piece of hard candy or glucose tablets with you to treat episodes of low blood sugar. Follow your diet, medication, and exercise routines closely. Changing any of them can affect blood sugar levels. Do not change your dose of tolbutamide without first talking to your doctor. Avoid alcohol. It lowers blood sugar and may interfere with your diabetes treatment.

Orinaz Organisms Affected

Humans and other mammals